| Bioactivity | Saracatinib-d3 (AZD0530-d3) (ZG5129) is the deuterium-labeled analog of Saracatinib (HY-10234). Saracatinib-d3 is an inhibitor of the Src kinase, which can inhibit severe sepsis caused by bacterial or various microbial infections[1]. |
| CAS | 2200301-36-4 |
| Formula | C27H29D3ClN5O5 |
| Molar Mass | 545.04 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Anning Lin. TREATMENT OF TNF-alpha CYTOTOXICITY. Patent WO2018045258, 2018-03-08. |
Saracatinib-d3
CAS: 2200301-36-4 F: C27H29D3ClN5O5 W: 545.04
Saracatinib-d3 (AZD0530-d3) (ZG5129) is the deuterium-labeled analog of Saracatinib (HY-10234). Saracatinib-d3 is an inh
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.